Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTSS-2
ISRCTN51505768Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, open-label trial of argatroban and tissue-plasminogen activator in ischemic stroke (3 arms), sponsored by UTHealth Houston. Primary endpoint: Excellent functional outcome at day 90. Started Mar 2013; status: completed.
02
Drugs
argatrobantissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ISRCTN51505768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51505768.